"Serum Institute"

Latest news and video coverage curated from trusted media outlets

Drug panel favours nod for Covovax as Covid booster An expert panel of the central drug regulatory authority has recommended market authorisation for Serum Institute of India’s Covid vaccine, Covovax, as a heterologous booster dose for adults who have.. IndiaTimes - Published on January 12, 2023
Covovax may get approval as heterologous booster The government may decide on allowing Serum Institute of India’s (SII) Covovax as a heterologous booster dose, meaning it can be used for people who have taken either Covishield or Covaxin for.. IndiaTimes - Published on January 10, 2023
Covid situation in India better than elsewhere: SII CEO Adar Poonawalla Serum Institute CEO Adar Poonawalla on Sunday lauded India's fight against the Covid pandemic, saying the government and the healthcare workers contributed largely to tackling the pandemic. "Everyone.. IndiaTimes - Published on January 9, 2023

Covid-19: Covovax to get approval as booster in 10-15 days, says SII CEO Adar Poonawalla Serum Institute of India chief executive officer Adar Poonawalla on Sunday said its Covovax vaccine will get approval as a booster in the next 10 to 15 days, adding it works very well against the.. IndiaTimes - Published on January 8, 2023

Search this site and the web: